Susan G Komen  
I've Been Diagnosed With Breast Cancer Someone I Know Was Diagnosed Share Your Story Join Us And Stay Informed Donate To End Breast Cancer
Home > Understanding Breast Cancer > Treatment > Aromatase Inhibitors

  


Aromatase Inhibitors

 

videoicon.jpg 

Hormone Therapy Video
Macromedia Flash

  

Hormone Therapy
Fact Sheet

videoicon.jpg 

Breast Cancer 101 (Interactive Media) - Aromatase Inhibitors
Macromedia Flash

Aromatase inhibitors and breast cancer treatment  

Aromatase inhibitors lower estrogen levels in the body by blocking aromatase, an enzyme that converts other hormones into estrogen.  

Like tamoxifen, aromatase inhibitors are used to treat metastatic and early breast cancers that are hormone-receptor positive. Aromatase inhibitors include:

  • Anastrozole (Arimidex)
  • Exemestane (Aromasin)
  • Letrozole (Femara)

Unlike tamoxifen, aromatase inhibitors are only used to treat postmenopausal women.  

Postmenopausal women with hormone receptor-positive breast cancer begin hormone therapy with an aromatase inhibitor or begin with tamoxifen and after a few years, switch to an aromatase inhibitor.  

Aromatase inhibitors come in a pill form and are taken every day. When aromatase inhibitors are the only hormone therapy given, they are taken for five years. When women switch to an aromatase inhibitor after taking tamoxifen for a few years, they take these drugs for a combined total of at least five years. More and more, hormone therapy is recommended for a longer period of time for postmenopausal women (five years of tamoxifen followed by five years of an aromatase inhibitor, for a total of 10 years of treatment). The number of years that aromatase inhibitors should be taken to get the most treatment benefit is still under study.

Benefits of aromatase inhibitors

Treatment with an aromatase inhibitor (alone or after several years of tamoxifen) lowers the risk of [57]:

Among postmenopausal women with hormone receptor-positive breast cancer, aromatase inhibitors (alone or after tamoxifen) offer the same or slightly better treatment benefit compared to treatment with tamoxifen alone [57,64-67]. The aromatase inhibitors anastrozole, exemestane and letrozole all have a similar treatment benefit [57,64-67]. They also have similar side effects. However, you may tolerate one drug better than another.

  

For a summary of research studies on aromatase inhibitors and early breast cancer, visit the Breast Cancer Research section.

 

Side effects of aromatase inhibitors  

The side effects of aromatase inhibitors differ from those of tamoxifen. Learn more about the side effects of aromatase inhibitors.

 

 Komen Support Resources  

 

 

Issues still under study  

At this time, we still do not know how long women should take aromatase inhibitors. There are no data on the benefits or safety of taking aromatase inhibitors for longer than five years.  

Another question is whether aromatase inhibitors benefit women who were premenopausal when diagnosed with breast cancer, but became menopausal due to treatment. New and ongoing studies should help answer these questions. Because aromatase inhibitors only work in postmenopausal women, tamoxifen should be used if there is any chance you are still premenopausal.  

Aromatase inhibitors are being studied in the chemoprevention (risk-lowering drugs) setting as well. Findings from randomized controlled trials have shown the aromatase inhibitors exemestane and anastrozole may lower the risk of developing breast cancer in postmenopausal women at high risk [68-69]. Exemestane and anastrozole do not yet have FDA-approval for use in the chemoprevention setting. Learn more about risk-lowering drugs for women at high risk of breast cancer.  

To learn more about aromatase inhibitors, visit the National Institutes of Health's Medline Plus website.

Importance of following your breast cancer treatment plan

Breast cancer treatment is most effective when all parts of the treatment plan are followed. So, it is important to follow your treatment plan (for medications and other therapies) prescribed by your health care provider in terms of:

  • Timing
  • Dose
  • Frequency

Completing hormone therapy with aromatase inhibitors

Hormone therapy used to treat breast cancer is typically prescribed for at least five years. The length of treatment coupled with side effects can make adherence to hormone therapy difficult. Although the menopausal symptoms related to hormone therapy can be hard to deal with, there are treatments that may ease these side effects. If you have side effects, talk to your health care provider about ways to treat them.  

To get the most benefit out of hormone therapy, you need to take the full course of treatment. Women who complete the full course have higher rates of survival [59].  

If you have trouble remembering to take your hormone therapy, a daily pillbox or setting an alarm on your watch or mobile device (you may be able to download a mobile app) may help [3]. However, you do not need to panic if you miss a day or two.  

Learn more about the importance of following your breast cancer treatment plan.

Prescription drug assistance

Anastrozole, exemestane and letrozole are off-patent and available in generic forms. Generics are cheaper than name brand drugs, but are just as effective.  

Medicare and many insurance providers offer prescription drug plans. One may already be included in your policy or you may be able to buy an extra plan for prescriptions. You may also qualify for assistance from programs that help with drug costs or offer low-cost or free prescriptions.  

Learn more about insurance plans and prescription drug assistance programs.  

Updated 04/30/14
 

previous  Tamoxifen 
previous  Side Effects of Tamoxifen